Van Vlierberghe H - Search Results

1

Haptoglobin polymorphisms and iron homeostasis in health and in disease.

Van Vlierberghe H, Langlois M, Delanghe J. Van Vlierberghe H, et al. Clin Chim Acta. 2004 Jul;345(1-2):35-42. doi: 10.1016/j.cccn.2004.03.016. Clin Chim Acta. 2004. PMID: 15193975 Review.

2

Association between Cys282Tyr missense mutation and haptoglobin phenotype polymorphism in patients with chronic hepatitis C.

Van Vlierberghe H, Delanghe JR, De Bie S, Praet M, De Paepe A, Messiaen L, De Vos M, Leroux-Roels G. Van Vlierberghe H, et al. Eur J Gastroenterol Hepatol. 2001 Sep;13(9):1077-81. doi: 10.1097/00042737-200109000-00014. Eur J Gastroenterol Hepatol. 2001. PMID: 11564959

3

Haptoglobin phenotype 2-2 overrepresentation in Cys282Tyr hemochromatotic patients.

Van Vlierberghe H, Langlois M, Delanghe J, Horsmans Y, Michielsen P, Henrion J, Cartuyvels R, Billiet J, De Vos M, Leroux-Roels G. Van Vlierberghe H, et al. J Hepatol. 2001 Dec;35(6):707-11. doi: 10.1016/s0168-8278(01)00203-3. J Hepatol. 2001. PMID: 11738096

4

Non-transferrin-bound iron in untreated and ribavirin-treated chronic hepatitis C patients.

Van Vlierberghe H, Verdievel H, Colle I, Delanghe J, Praet M, Bernard D, Leroux-Roels G, De Vos M. Van Vlierberghe H, et al. Aliment Pharmacol Ther. 2002 Aug;16(8):1555-62. doi: 10.1046/j.1365-2036.2002.01316.x. Aliment Pharmacol Ther. 2002. PMID: 12182756 Free article.

5

Haptoglobin polymorphism and iron hemostasis.

Van Vlierberghe H, Delanghe J. Van Vlierberghe H, et al. Clin Chem. 2003 Apr;49(4):708-9. doi: 10.1373/49.4.708. Clin Chem. 2003. PMID: 12651841 No abstract available.

6

Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics.

Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R. Callewaert N, et al. Among authors: van vlierberghe h, van hecke a. Nat Med. 2004 Apr;10(4):429-34. doi: 10.1038/nm1006. Nat Med. 2004. PMID: 15152612

7

Analysis of gamma-globulin mobility on routine clinical CE equipment: exploring its molecular basis and potential clinical utility.

Vanderschaeghe D, Debruyne E, Van Vlierberghe H, Callewaert N, Delanghe J. Vanderschaeghe D, et al. Among authors: van vlierberghe h. Electrophoresis. 2009 Aug;30(15):2617-23. doi: 10.1002/elps.200900054. Electrophoresis. 2009. PMID: 19621379

8

Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients.

Debruyne EN, Vanderschaeghe D, Van Vlierberghe H, Vanhecke A, Callewaert N, Delanghe JR. Debruyne EN, et al. Among authors: van vlierberghe h. Clin Chem. 2010 May;56(5):823-31. doi: 10.1373/clinchem.2009.139295. Epub 2010 Mar 26. Clin Chem. 2010. PMID: 20348404 Free article.

9

Donor haptoglobin phenotype determines outcome following liver transplantation.

Speeckaert R, Van Vlierberghe H, Troisi R, De Bacquer D, Speeckaert MM, De Buyzere ML, Claeys L, de Hemptinne B, Delanghe JR. Speeckaert R, et al. Among authors: van vlierberghe h. Transpl Int. 2011 Jun;24(6):619-26. doi: 10.1111/j.1432-2277.2011.01246.x. Epub 2011 Mar 14. Transpl Int. 2011. PMID: 21401731 Free article.

10

CE analysis of γ-globulin mobility and potential clinical utility.

Vanderschaeghe D, Debruyne E, Van Vlierberghe H, Callewaert N, Delanghe J. Vanderschaeghe D, et al. Among authors: van vlierberghe h. Methods Mol Biol. 2013;919:249-57. doi: 10.1007/978-1-62703-029-8_22. Methods Mol Biol. 2013. PMID: 22976106

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

335 results

Search Page